The epidemiology of cancer of the small bowel, Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. mars, vol.7, issue.3, pp.243-51, 1998. ,
Incidence and Management of Primary Malignant Small Bowel Cancers: A Well-defined French Population Study, The American Journal of Gastroenterology, vol.14, issue.5, pp.2826-2858, 2006. ,
DOI : 10.1016/S0959-8049(96)00244-4
Descriptive epidemiology of small intestinal malignancies: the German Cancer Registry experience, British Journal of Cancer, vol.80, issue.9, pp.1440-1444, 1999. ,
DOI : 10.1038/sj.bjc.6690541
Small Bowel Cancer in the United States, Annals of Surgery, vol.249, issue.1, pp.63-71, 2009. ,
DOI : 10.1097/SLA.0b013e31818e4641
Adenocarcinoma of the small bowel at a single Korean institute: management and prognosticators, Journal of Cancer Research and Clinical Oncology, vol.151, issue.3, pp.387-94, 2009. ,
DOI : 10.1007/s00432-009-0668-3
NADEGE prospective cohort: demographic data of 343 patients with small bowel adenocarcinoma, Eur Cancer Congress, vol.34, pp.6-7, 2013. ,
Is there a role for adjuvant therapy in resected adenocarcinoma of the small intestine, Acta Oncologica, vol.147, issue.4, pp.474-483, 2010. ,
DOI : 10.1001/archsurg.137.5.564
Programmed death-ligand 1 (PD-L1) expression in small bowel adenocarcinomas (SBA), J Clin Oncol, vol.3619, 2015. ,
Adenocarcinoma of the small bowel, Cancer, vol.180, issue.12, pp.2693-706, 1985. ,
DOI : 10.1002/(SICI)1097-0142(19991215)86:12<2693::AID-CNCR14>3.0.CO;2-U
Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995???2002, European Journal of Cancer, vol.48, issue.10, pp.1417-1441, 2011. ,
DOI : 10.1016/j.ejca.2011.10.038
URL : https://hal.archives-ouvertes.fr/hal-00719134
A single-institution experience with 491 cases of small bowel adenocarcinoma, The American Journal of Surgery, vol.199, issue.6, pp.797-803, 2010. ,
DOI : 10.1016/j.amjsurg.2009.05.037
Multicenter retrospective study of 132 patients with unresectable small bowel adenocarcinoma treated with chemotherapy. The oncologist, pp.1163-70, 2012. ,
Chemotherapy of advanced small-bowel adenocarcinoma: a multicenter AGEO study, Annals of Oncology, vol.21, issue.9, pp.1786-93, 2010. ,
DOI : 10.1093/annonc/mdq038
URL : https://hal.archives-ouvertes.fr/hal-00618071
Small-Bowel Tumors, Archives of Surgery, vol.142, issue.3, pp.229-264, 2007. ,
DOI : 10.1001/archsurg.142.3.229
Cancer Statistics, 2008, CA: A Cancer Journal for Clinicians, vol.58, issue.2, pp.71-96, 2008. ,
DOI : 10.3322/CA.2007.0010
A Population-Based Study of the Incidence of Malignant Small Bowel Tumours: SEER, 1973???1990, International Journal of Epidemiology, vol.25, issue.4, pp.722-730, 1996. ,
DOI : 10.1093/ije/25.4.722
Adenocarcinoma of the small bowel, Cancer, vol.101, issue.3, pp.518-544, 2004. ,
DOI : 10.1002/cncr.20404
Small bowel adenocarcinoma in patients with Crohn's disease compared with small bowel adenocarcinoma de novo, Inflamm Bowel Dis, vol.11, issue.9, pp.828-860, 2005. ,
A Population-Based Comparison of Adenocarcinoma of the Large and Small Intestine: Insights Into a Rare Disease, Annals of Surgical Oncology, vol.28, issue.5, pp.1439-1484, 2012. ,
DOI : 10.1245/s10434-011-2173-6
Primary Cancers of the Small Bowel, Archives of Surgery, vol.137, issue.5, pp.564-71, 2002. ,
DOI : 10.1001/archsurg.137.5.564
Cohorte NADEGE: données démographiques sur 343 patients atteints d'adénocarcinome de l'intestin grêle, JFHOD, vol.007799, 2014. ,
Small bowel adenocarcinoma: Epidemiology, risk factors, diagnosis and treatment, Digestive and Liver Disease, vol.46, issue.2, 2013. ,
DOI : 10.1016/j.dld.2013.04.013
Smoking, alcohol use, dietary factors and risk of small intestinal adenocarcinoma, International Journal of Cancer, vol.43, issue.5, pp.512-519, 1997. ,
DOI : 10.1002/(SICI)1097-0215(19970304)70:5<512::AID-IJC4>3.0.CO;2-0
Is there an association between alcohol intake or smoking and small bowel adenocarcinoma? Results from a European multi-center casecontrol study, Cancer Causes and Control, vol.11, issue.9, pp.791-798, 2000. ,
DOI : 10.1023/A:1008920502888
Risk factors for small intestine cancer, Cancer Causes and Control, vol.1, issue.2, pp.163-172, 1993. ,
DOI : 10.1007/BF00053158
Risk factors for adenocarcinoma of the small intestine, International Journal of Cancer, vol.70, issue.2, pp.171-175, 1999. ,
DOI : 10.1002/(SICI)1097-0215(19990719)82:2<171::AID-IJC3>3.0.CO;2-T
Pathogenesis and Risk Factors of Small Bowel Adenocarcinoma: A Colorectal Cancer Sibling?, The American Journal of Gastroenterology, vol.13, issue.3, pp.703-713, 2005. ,
DOI : 10.1016/0002-9610(78)90158-7
Mutational activation of the RAS???RAF???MAPK and the wnt pathway in small intestinal adenocarcinomas, Scandinavian Journal of Gastroenterology, vol.56, issue.8, pp.748-53, 2004. ,
DOI : 10.1080/00365520410005847
An insight into the genetic pathway of adenocarcinoma of the small intestine, Gut, vol.50, issue.2, pp.218-241, 2002. ,
DOI : 10.1136/gut.50.2.218
Mutations of the Ki???ras, p53 and APC genes in adenocarcinomas of the human small intestine, International Journal of Cancer, vol.70, issue.4, pp.390-395, 1997. ,
DOI : 10.1002/(SICI)1097-0215(19970207)70:4<390::AID-IJC3>3.3.CO;2-S
Genetics of adenocarcinomas of the small intestine: frequent deletions at chromosome 18q and mutations of the SMAD4 gene, Oncogene, vol.59, issue.1, pp.158-64, 2002. ,
DOI : 10.1038/sj.onc.1205041
Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study, British Journal of Cancer, vol.7, issue.12, pp.3057-66, 2013. ,
DOI : 10.1002/(SICI)1096-9098(199602)61:2<100::AID-JSO3>3.0.CO;2-G
Large-scale N-terminal deletions but not point mutations stabilize ??-catenin in small bowel carcinomas, suggesting divergent molecular pathways of small and large intestinal carcinogenesis, The Journal of Pathology, vol.15, issue.3, pp.300-307, 2008. ,
DOI : 10.1002/path.2362
Immunohistochemical analysis of adenocarcinoma of the small intestine: a tissue microarray study, Journal of Clinical Pathology, vol.56, issue.12, pp.898-903, 2003. ,
DOI : 10.1136/jcp.56.12.898
ERBB2 gene as a potential therapeutic target in small bowel adenocarcinoma, European Journal of Cancer, vol.50, issue.10, pp.1740-1746, 2014. ,
DOI : 10.1016/j.ejca.2014.04.007
Small Bowel Adenocarcinoma Phenotype According To The Primary Localisation, Annals of Oncology, vol.23, issue.9, pp.234-235, 2012. ,
Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine, British Journal of Cancer, vol.61, issue.1, pp.144-50, 2010. ,
DOI : 10.1038/sj.bjc.6605449
Microsatellite instability and expression of MLH1 and MSH2 in carcinomas of the small intestine, Cancer, vol.65, issue.6, pp.1551-1558, 2003. ,
DOI : 10.1002/cncr.11197
Durable Cancer Regression Off-Treatment and Effective Reinduction Therapy with an Anti-PD-1 Antibody, Clinical Cancer Research, vol.19, issue.2, pp.462-470, 2013. ,
DOI : 10.1158/1078-0432.CCR-12-2625
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency, New England Journal of Medicine, vol.372, issue.26, pp.2509-2529, 2015. ,
DOI : 10.1056/NEJMoa1500596
Small bowel adenocarcinoma copy number profiles are more closely related to colorectal than to gastric cancers, Annals of Oncology, vol.23, issue.2, pp.367-74, 2012. ,
DOI : 10.1093/annonc/mdr122
The risk of upper gastrointestinal cancer in familial adenomatous polyposis, Gastroenterology, vol.102, issue.6, 1992. ,
DOI : 10.1016/0016-5085(92)90322-P
UPPER GASTROINTESTINAL CANCER IN FAMILIAL ADENOMATOUS POLYPOSIS, The Lancet, vol.331, issue.8595, pp.1149-51, 1988. ,
DOI : 10.1016/S0140-6736(88)91962-9
Duodenal adenomatosis in familial adenomatous polyposis, International Journal of Colorectal Disease, vol.14, issue.1, pp.43-49, 1995. ,
DOI : 10.1007/BF00337586
Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis, Gastroenterology, vol.110, issue.4, pp.1020-1027, 1996. ,
DOI : 10.1053/gast.1996.v110.pm8612988
French Cancer Genetics Network. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome, JAMA. 8 juin, vol.305, issue.22, pp.2304-2314, 2011. ,
Small-bowel capsule endoscopy diagnoses early and advanced neoplasms in asymptomatic patients with Lynch syndrome, Endoscopy, vol.42, issue.12, pp.1057-62, 2010. ,
DOI : 10.1055/s-0030-1255742
Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts, Gut, vol.62, issue.6, pp.812-835, 2013. ,
DOI : 10.1136/gutjnl-2012-304356
Small bowel carcinoma revealing HNPCC syndrome, Gastroent??rologie Clinique et Biologique, vol.34, issue.4-5, pp.4-5325, 2010. ,
DOI : 10.1016/j.gcb.2010.04.007
Very high risk of cancer in familial Peutz???Jeghers syndrome, Gastroenterology, vol.119, issue.6, pp.1447-53, 2000. ,
DOI : 10.1053/gast.2000.20228
Cancer risk in patients with inflammatory bowel disease, Cancer, vol.77, issue.4, pp.854-62, 2001. ,
DOI : 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z
P071 RISK FACTORS ASSOCIATED WITH SMALL BOWEL ADENOCARCINOMA IN CROHN'S DISEASE: A CASE-CONTROL STUDY, Journal of Crohn's and Colitis Supplements, vol.1, issue.1, pp.1730-1736, 2008. ,
DOI : 10.1016/S1873-9954(07)70083-6
Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis, Gastroenterology, vol.123, issue.5, pp.1428-1463, 2002. ,
DOI : 10.1053/gast.2002.36585
Prognostic Factors of Primary Small Bowel Adenocarcinoma: Univariate and Multivariate Analysis, World Journal of Surgery, vol.101, issue.3, pp.391-399, 2006. ,
DOI : 10.1007/s00268-005-7898-6
Small Bowel Adenocarcinoma: Understaged and Undertreated?, Annals of Surgical Oncology, vol.113, issue.10, pp.2728-2760, 2010. ,
DOI : 10.1245/s10434-010-1109-x
Prognostic value of lymph node evaluation in small bowel adenocarcinoma, Cancer, vol.27, issue.23, pp.5374-82, 2010. ,
DOI : 10.1002/cncr.25324
Extent of resection in the management of duodenal adenocarcinoma, The American Journal of Surgery, vol.179, issue.1, pp.37-41, 2000. ,
DOI : 10.1016/S0002-9610(99)00269-X
Adenocarcinoma of the duodenum: factors influencing long-term survival, Journal of Gastrointestinal Surgery, vol.2, issue.1, pp.79-87, 1998. ,
DOI : 10.1016/S1091-255X(98)80107-8
Prognostic factors and treatment outcomes in patients with Small Bowel Adenocarcinoma (SBA): The Royal Marsden Hospital (RMH) experience, BMC Cancer, vol.17, issue.4, 2015. ,
DOI : 10.1007/s10120-013-0328-9
Systemic chemotherapy for treatment of advanced small bowel adenocarcinoma with prognostic factor analysis: retrospective study, BMC Cancer, vol.27, issue.16, 2011. ,
DOI : 10.1200/JCO.2008.19.7145
Efficacy of the FOLFOX/CAPOX regimen for advanced small bowel adenocarcinoma: a three-center study from China, J BUON Off J Balk Union Oncol. déc, vol.16, issue.4, pp.689-96, 2011. ,
Second-line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first-line platinum-based chemotherapy, Cancer, vol.9, issue.7, pp.1422-1430, 2011. ,
DOI : 10.1002/cncr.25614
Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma, Cancer, vol.134, issue.8, pp.2038-2083, 2008. ,
DOI : 10.1002/cncr.23822
Chemotherapy in Small Bowel Adenocarcinoma: 10-year Experience of the British Columbia Cancer Agency, Clinical Oncology, vol.19, issue.2, pp.143-152, 2007. ,
DOI : 10.1016/j.clon.2006.12.001
A phase II study of modified FOLFOX as first-line chemotherapy in advanced small bowel adenocarcinoma, Anti-Cancer Drugs, vol.23, issue.5, pp.561-567, 2012. ,
DOI : 10.1097/CAD.0b013e328350dd0d
Pharmacogenetic dosing by UGT1A1 genotype as first-line therapy for advanced small-bowel adenocarcinoma: A North Central Cancer Treatment Group (NCCTG) trial., Journal of Clinical Oncology, vol.30, issue.4_suppl, 2012. ,
DOI : 10.1200/jco.2012.30.4_suppl.314
Phase II Study of Capecitabine and Oxaliplatin for Advanced Adenocarcinoma of the Small Bowel and Ampulla of Vater, Journal of Clinical Oncology, vol.27, issue.16, pp.2598-603, 2009. ,
DOI : 10.1200/JCO.2008.19.7145
Phase II study of 5-fluorouracil, doxorubicin, and mitomycin C for metastatic small bowel adenocarcinoma. The oncologist, pp.132-139, 2005. ,
Survival in small intestinal adenocarcinoma, European Journal of Cancer, vol.32, issue.12, pp.2114-2123, 1990. ,
DOI : 10.1016/S0959-8049(96)00244-4
Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer, Journal of Clinical Oncology, vol.21, issue.20, pp.3737-3780, 2003. ,
DOI : 10.1200/JCO.2003.04.187
Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy, Journal of Clinical Oncology, vol.27, issue.22, pp.3677-83, 2009. ,
DOI : 10.1200/JCO.2008.20.5278
Factors influencing long-term survival in 100 cases of small intestine primary adenocarcinoma, The American Journal of Surgery, vol.173, issue.3, pp.237-246, 1997. ,
DOI : 10.1016/S0002-9610(97)89599-2
Prognostic Factors and Survival after Resection of Colorectal Liver Metastasis in the Era of Preoperative Chemotherapy: An 11-Year Single-Centre Study, Digestive Surgery, vol.30, issue.4-6, pp.4-6293, 2013. ,
DOI : 10.1159/000354310
Evaluation of Long-term Survival After Hepatic Resection for Metastatic Colorectal Cancer, Annals of Surgery, vol.247, issue.1, pp.125-160, 2008. ,
DOI : 10.1097/SLA.0b013e31815aa2c2
Margin Status Remains an Important Determinant of Survival After Surgical Resection of Colorectal Liver Metastases in the Era of Modern Chemotherapy, Annals of Surgery, vol.257, issue.6, pp.1079-88, 2013. ,
DOI : 10.1097/SLA.0b013e318283a4d1
Early Recurrence After Liver Resection for Colorectal Metastases: Risk Factors, Prognosis, and Treatment. A LiverMetSurvey-Based Study of 6,025 Patients, Annals of Surgical Oncology, vol.26, issue.6, pp.1276-86, 2013. ,
DOI : 10.1245/s10434-013-3421-8
Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial, Journal of Clinical Oncology, vol.27, issue.19, pp.3109-3125, 2009. ,
DOI : 10.1200/JCO.2008.20.6771
Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses, Journal of Clinical Oncology, vol.29, issue.28, pp.3768-74, 2011. ,
DOI : 10.1200/JCO.2011.36.4539
Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer, Journal of Clinical Oncology, vol.29, issue.11, pp.1465-71, 2011. ,
DOI : 10.1200/JCO.2010.33.6297
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial, The Lancet, vol.371, issue.9617, pp.1007-1023, 2008. ,
DOI : 10.1016/S0140-6736(08)60455-9